TITLE

Metoprolol responding uveitis

AUTHOR(S)
Masood, I
PUB. DATE
June 2005
SOURCE
Eye;Jun2005, Vol. 19 Issue 6, p719
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor referring to a case of panuveitis responding to oral metoprolol therapy.
ACCESSION #
17230831

 

Related Articles

  • Metoprolol responding uveitis: reply. Kassif, Y; Rehany, U; Rumelt, S // Eye;Jun2005, Vol. 19 Issue 6, p720 

    Presents a letter to the editor in response to a comment about the use of metoprolol for uveitis.

  • Adalimumab Therapy for Refractory Uveitis: A Pilot Study. Callejas-Rubio, José Luis; Sánchez-Cano, Daniel; Serrano, José Luis García; Ortego-Centeno, Norberto // Journal of Ocular Pharmacology & Therapeutics;Dec2008, Vol. 24 Issue 6, p613 

    A letter to the editor is presented in response to the article "Adalimumab therapy for refractory uveitis: A pilot study," by Manuel Dfaz-Llopis, Salvador Garcia-Delpech, and David Salom in the 2008 issue, along with a corresponding reply.

  • Tuberculoma of the choroid masquerading as a choroidal melanoma. Papastefanou, V P; Cohen, V M // Eye;Nov2011, Vol. 25 Issue 11, p1519 

    A letter to the editor is presented in response to the article "Presumed tuberculous uveitis: diagnosis, management, and outcome," by C. Sanghvi and colleagues.

  • Tocilizumab treatment for recalcitrant uveitic macular edema. Adán, Alfredo; Llorenç, Victor; Mesquida, Marina; Pelegrín, Laura // Graefe's Archive of Clinical & Experimental Ophthalmology;Sep2013, Vol. 251 Issue 9, p2249 

    No abstract available.

  • Consider referral for uveitis. Sweeney, Tara // Ophthalmology Times;8/15/96, Vol. 21 Issue 22, p16 

    Reports that delayed referral is one of the factor for the decreased outcome in uveitis treatment, according to Stephen Foster of the Massachusetts Eye & Ear Infirmary (MEEI) in Boston. Responsibility of general ophthalmologist to refer uveitis patients for multiple recurrences, granulomatous...

  • Uveitis and rifabutin therapy.  // American Family Physician;11/1/1994, Vol. 50 Issue 6, p1391 

    Reports that rifabutin (Myscobutin) therapy is associated with the development of uveitis. Recommendation of the U.S. Public Health Service Task Force n 1993 of rifabutin; Possibility of uveitis on administration of higher doses of rifabutin.

  • Management of Immune-Mediated Uveitis. Smith, J.R.; Rosenbaum, J.T. // BioDrugs;2000, Vol. 13 Issue 1, p9 

    Immune-mediated uveitis is a collective term referring to a group of potentially blinding intraocular inflammations which may coexist with systemic inflammatory diseases. T lymphocytes appear to play an important pathogenic role in uveitis, and these cells are therefore the logical target of...

  • Treat early and embrace the evidence in favour of anti-TNF-α therapy for Behçet's uveitis. Lee, Richard W. J.; Dick, Andrew D. // British Journal of Ophthalmology;Mar2010, Vol. 94 Issue 3, p2 

    The author reflects on the need to embrace medical developments in favor of the anti-tumour necrosis factor therapy for the treatment of Behcet's uveitis.

  • 2010 SFO rapport focuses on complex management of uveitis.  // Ocular Surgery News;6/25/2010, Vol. 28 Issue 12, p18 

    The article provides information about the complex management of uveitis, according to Antoine Brézin, coordinator of the 2010 SFO rapport on uveitis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics